lymph nodes) for patients with early breast cancer improves overall survival function.‘We hope to see a survival benefit of at least five % of patients at the time of the primary,’ said Poortmans. ‘With a median follow up of more than seven years, 558 patients died, so the estimated 10 years, overall survival of 79 percent -83 percent range is even greater than anticipated,’ he added.
The initial results of the 4004-patient multicenter study conducted by the EORTC radiotherapy group and breast cancer show that there is no evidence of increased toxicity in the heart of three years of follow-up patients who received radiotherapy additional lymph nodes.
In patients with early breast cancer, giving radiotherapy to the lymph nodes behind the breastbone and above the clavicle is well tolerated after a lumpectomy or mastectomy, a radiation oncologist told delegates at the Seventh European Conference against breast cancer March 27 . Women at high risk of developing breast cancer, probably benefit from additional radiotherapy of lymph nodes, Dr. Philip Poortmans, Dr. Bernard Verbeeten Instituut, Tilburg, the Netherlands and a member of the EORTC Radiation Oncology Group *, he said
Pediatricians should support and defend a law to prohibit access to tanning beds for children under 18 years, the AAP said in its policy statement on ultraviolet radiation, published in the March issue of Pediatrics.
Patients will be followed for many years to see whether specific lymph node radiotherapy could lead to long-term damage of the heart or lungs, the side effects associated with radiotherapy for breast cancer.
Radiotherapy is usually given after surgery for breast cancer cells to destroy the remaining cancer of the breast, chest wall, or underarm area to reduce the risk of local recurrence of breast cancer in this. But there is disagreement among cancer specialists in the management of internal mammary lymph nodes in patients with breast cancer. The question of whether specific internal mammary lymph node radiotherapy leads to improved survival in women with early breast cancer is being considered by the EORTC radiotherapy and breast cancer groups.
Philip Poortmans, one of the coordinators of the test, told delegates that the long-term goal of the EORTC study is to see whether giving additional radiotherapy lymph nodes behind the breastbone and above the collar bone (internal mammary and medial supraclavicular